Taken together, these lines of evidence indicate that the TCN1/STAT4/DUOX2/ROS cascade constitutes a tumor cell-autonomous regulatory pathway distinct from the modes of STAT4 activation observed in immune or stromal cells [35], thereby highlighting a PDAC-specific, cell type–restricted regulatory milieu and potential actionable points of intervention. Here, DUOX2 is linked to neoplasm.